Pharmacological modulation of platelet function in hypertension

被引:79
作者
Blann, AD [1 ]
Nadar, S [1 ]
Lip, GYH [1 ]
机构
[1] City Hosp, Univ Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
关键词
platelet activation; hypertension; chronic; antihypertensive therapy;
D O I
10.1161/01.HYP.0000077901.84467.E1
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Platelets exert a considerable influence on human morbidity and mortality. The rationale for their study in hypertension follows the observation that the major consequences of hypertension are stroke and myocardial infarction. However, the etiology of these consequences in hypertension is, paradoxically, not hemorrhagic (as might be expected from the effects of high blood pressure), but occlusive, with thrombus being the culprit lesion. Mechanisms of platelet activation include high shear force, activation of the renin-angiotensin system, endothelial changes, and the presence of comorbidity, such as atrial fibrillation. The treatment of high blood pressure brings about a reversal of the changes seen in the cell. This could be in part due to the direct effect of the drug on the megakaryocyte and/or the platelets themselves, or it might simply be due to the reduction in blood pressure. Some drugs, such as calcium channel antagonists and angiotensin II receptor blockers, however, might have direct effects on platelet biochemistry other than reducing blood pressure. Finally, antiplatelet drugs are becoming an important part of the management of high-risk hypertensives, which aim to minimize vascular complications.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 108 条
[1]   EFFECTS OF VERAPAMIL AND DILTIAZEM ON HUMAN-PLATELET FUNCTION [J].
ADDONIZIO, VP ;
FISHER, CA ;
STRAUSS, JF ;
WACHTFOGEL, YT ;
COLMAN, RW ;
JOSEPHSON, ME .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 250 (03) :H366-H371
[2]   INHIBITION OF HUMAN-PLATELET FUNCTION BY VERAPAMIL [J].
ADDONIZIO, VP ;
FISHER, CA ;
STRAUSS, JF ;
EDMUNDS, LH .
THROMBOSIS RESEARCH, 1982, 28 (04) :545-556
[3]  
Andrews RK, 2001, HISTOL HISTOPATHOL, V16, P969, DOI 10.14670/HH-16.969
[4]   THE EFFECT OF NIFEDIPINE AND CAPTOPRIL ON PLATELET ACTIVATION AND PROSTANOID PRODUCTION IN ESSENTIAL-HYPERTENSION [J].
BIRKEBAEK, NH ;
VEJBYCHRISTENSEN, H ;
JAKOBSEN, P ;
WINTHER, K .
JOURNAL OF HYPERTENSION, 1988, 6 :S378-S380
[5]  
BLANN AD, 1993, J HUM HYPERTENS, V7, P107
[6]   Secondary endothelial dysfunction: Hypertension and heart failure [J].
Boulanger, CM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1999, 31 (01) :39-49
[7]   Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG Study [J].
Breddin, HK ;
Lippold, R ;
Bittner, M ;
Kirchmaier, CM ;
Krzywanek, HJ ;
Michaelis, J .
ATHEROSCLEROSIS, 1999, 144 (01) :211-219
[8]  
Brodde O E, 1984, J Hypertens Suppl, V2, pS111
[9]  
Brown N J, 2000, Adv Intern Med, V45, P419
[10]  
Buczko W, 2001, Med Sci Monit, V7, P600